Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1715717

registered interest
date	02/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Private Sector
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what clinical regulation measures are in place to ensure that care and treatments provided by private medical insurers are the most appropriate for a specific patient.
tabling member printed	Baroness Merron
uin	HL4346
answer	answer is ministerial correction date of answer 09/05/2024 answer text <p>Private medical insurers do not provide care or treatment. However, they do purchase services from independent sector providers who are responsible for delivering healthcare. All providers of healthcare undertaking regulated activities, as defined in Schedule 1 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, are regulated by the Care Quality Commission, and follow a set of fundamental standards of safety and quality, while the health and care regulators are responsible for regulating health and care professionals.</p><p>Regulations 9 and 12 of the 2014 regulations set out the importance of person-centred care, and safe care and treatment. These regulations have the intention of ensuring that people using a service have care or treatment that is personalised specifically for them, preventing people from receiving unsafe care and treatment, and thereby precluding avoidable harm or risk of harm.</p> answering member printed Lord Markham question first answered 09/05/2024 16:40:38 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1713997

registered interest
date	25/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what practical assistance is available for those with a physical or mental condition which prevents them from doing medical tests at home, such as bowel cancer screening, unaided.
tabling member printed	Baroness Merron
uin	HL4104
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>We are aware of the issues faced by some people with physical or mental health conditions that can make attending a screening appointment, or carrying out a home test, more difficult. Currently, national screening IT systems do not have the facilities to flag conditions for individuals which could make it more difficult to carry out the bowel cancer screening, fecal immunochemical test (FIT) at home. It is therefore recommended that individuals contact their general practice (GP) in these situations, so that GPs can work with the screening provider to arrange further support. For example, carrying out a FIT test at the GP or at home, with the support of a family member or community nurse.</p><p> </p><p>NHS England has started work to improve its national screening IT systems through the Digital Transformation of Screening programme. This will enable screening providers to flag heath issues that may make carrying out a FIT test at home more difficult, and to offer any appropriate support.</p> answering member printed Lord Markham question first answered 01/05/2024 14:23:21 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1713998

registered interest
date	25/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government which groups have a lower-than-average rate of participation in home-kit bowel cancer screening; and what plans they have to increase participation.
tabling member printed	Baroness Merron
uin	HL4105
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>The national IT system for the NHS Bowel Cancer Screening Programme does not routinely collect data that could identify groups that have a lower-than-average uptake rate of the fecal immunochemical bowel cancer screening test.</p><p>Research has found that groups which are less likely to take part in bowel screening include men, people from ethnic minority backgrounds, and people in more deprived areas. Physical or mental health conditions can also make carrying out a home test more difficult.</p><p>NHS England has started work to improve its national screening IT systems through the Digital Transformation of Screening programme. This will enable screening providers to record protected characteristics, to more accurately identify groups with the lowest uptake, and target initiatives to improve uptake.</p> answering member printed Lord Markham question first answered 01/05/2024 14:23:51 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1701979

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Staff
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the potential impact on the mental health and wellbeing of secondary care staff if their partnership with NHS Practitioner Health is ended after the 12-month review period.
tabling member printed	Baroness Merron
uin	HL3894
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>We recognise that the NHS Practitioner Health service is valued by many doctors. NHS England is reviewing the service as part of a wider review of its mental health and wellbeing offer to National Health Service staff. It was confirmed on 15 April 2024 that the service will continue to accept new patients from primary and secondary care whilst this review is undertaken over the next 12 months. NHS England will assess the impact and confirm future arrangements once the review has been completed.</p> answering member printed Lord Markham question first answered 23/04/2024 16:06:17 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1701980

registered interest
date	17/04/2024
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Health Insurance: Private Sector
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to assess and mitigate the impact of private medical insurance fees on the quality and suitability of care provided to patients with private medical insurance.
tabling member printed	Baroness Merron
uin	HL3895
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>The Government is determined that all insurers, including private medical insurers, treat consumers fairly and firms are required to do so under the Financial Conduct Authority’s rules.</p><p> </p><p>The FCA requires insurers to ensure their products offer fair value, meaning the price a consumer pays for a product or service must be reasonable compared to the overall benefits they can expect to receive. The FCA has been clear that it will be monitoring firms to make sure they comply with this rule and will take action where necessary.</p><p> </p><p>All providers of healthcare are regulated by the Care Quality Commission and follow a set of fundamental standards of safety and quality below which care should never fall, while the General Medical Council is responsible for regulating doctors in the United Kingdom.</p><p> </p> answering member printed Baroness Vere of Norbiton question first answered 24/04/2024 11:43:25 answering member 4580 label Biography information for Baroness Vere of Norbiton
tabling member	347 label Biography information for Baroness Merron

1701981

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Insurance: Private Sector
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what regulations are in place to ensure that the care and treatment provided by private medical insurers are the most appropriate for a specific patient.
tabling member printed	Baroness Merron
uin	HL3896
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>Private medical insurers purchase services from independent sector providers who are responsible for delivering healthcare.</p><p>All providers of healthcare are regulated by the Care Quality Commission and follow a set of fundamental standards of safety and quality below which care should never fall, while the General Medical Council is responsible for regulating doctors in the United Kingdom.</p> answering member printed Lord Markham question first answered 23/04/2024 16:04:59 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1698035

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	MMR Vaccine: Pharmacy
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the potential for community pharmacists to administer the MMR vaccine.
tabling member printed	Baroness Merron
uin	HL3529
answer	answer is ministerial correction date of answer 02/04/2024 answer text <p>As part of the national measles, mumps, and rubella (MMR) improvement plan, NHS England has worked with regional commissioners to assess the potential for community pharmacy to deliver MMR vaccines, as part of a longer-term approach to improving uptake.</p><p>In specific response to the current measles outbreak, some areas have stood up community pharmacy sites on a time-limited basis to deliver the MMR vaccine to specific cohorts, based on local population need. For example, in the North West and the Midlands, National Health Service teams have used community pharmacies to step up their efforts to get more children protected with the MMR vaccine.</p><p>Using community pharmacy in this way will help to test the concept of community pharmacy playing a greater role in the delivery of vaccinations, and will support the integrated care boards’ work to develop a more coherent approach to vaccines, including where, when, and how to deliver them to maximise uptake, particularly in underserved populations.</p> answering member printed Lord Markham question first answered 02/04/2024 13:43:37 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1698036

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicine: Apprentices
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 16 February (HL2398), whether they have increased the maximum funding for medical degree apprentices from £50,000 to £150,000 over the term of the course.
tabling member printed	Baroness Merron
uin	HL3530
answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The funding of £150,000 to be provided by NHS England per medical degree apprentice is an increase of the funding of £50,000 for medical degree apprentices announced by Health Education England in January 2023.</p> answering member printed Lord Markham question first answered 05/04/2024 13:06:42 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1694706

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 1 February (HL1933), what are the agreed efficiency standards following restoration of breast screening services since the COVID-19 pandemic; how this decision was made; and by whom.
tabling member printed	Baroness Merron
uin	HL3117
answer	answer is ministerial correction date of answer 13/03/2024 answer text <p>The standards for breast screening include an acceptable uptake and coverage level of greater than or equal to 70%, and an achievable uptake and coverage level of greater than or equal to 80%. Full details about the changes to breast screening standards before and after COVID-19, are available on the GOV.UK website, in an online only format.</p> answering member printed Lord Markham grouped question UIN HL3118 question first answered 13/03/2024 14:08:46 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1694707

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 1 February (HL1933), what were the agreed efficiency standards for breast cancer screening prior to the restoration of services since the COVID-19 pandemic; and what are the agreed efficiency standards now.
tabling member printed	Baroness Merron
uin	HL3118
answer	answer is ministerial correction date of answer 13/03/2024 answer text <p>The standards for breast screening include an acceptable uptake and coverage level of greater than or equal to 70%, and an achievable uptake and coverage level of greater than or equal to 80%. Full details about the changes to breast screening standards before and after COVID-19, are available on the GOV.UK website, in an online only format.</p> answering member printed Lord Markham grouped question UIN HL3117 question first answered 13/03/2024 14:08:46 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron